🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nichelle C. Whitlock

National Cancer Institute

ORCID: 0000-0001-7321-4446
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer”.

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w
N/A
0.825DataRank · unranked
244 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851
N/A
0.529DataRank · unranked
33 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

Discover Oncology(2022)10.1007/s12672-022-00565-3
N/A
0.330DataRank · unranked
8 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900
N/A
0.172DataRank · unranked
2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799
N/A
0.165DataRank · unranked
2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445
N/A
0DataRank · unranked
0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395
N/A
0DataRank · unranked
4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

Oncogene(2020)10.1038/s41388-020-01389-7
N/A
0DataRank · unranked
34 citations

Shana Y. Trostel, Scott Wilkinson, Nicholas T. Terrigino, S. Thomas Hennigan, Ross Lake +8 more

Discovery and performance of DNA methylation panels for cancer detection and classification in blood

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.16.676542
N/A
0DataRank · unranked
0 citations

Sara R. Bang-Christensen, Sara A. Grimm, Brian D. Bennett, Peter Kilfeather, Kevin Fedkenheuer +12 more

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711
N/A
0DataRank · unranked
12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009
N/A
0DataRank · unranked
74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

The Journal of Urology(2022)10.1097/ju.0000000000002492
N/A
0DataRank · unranked
5 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Nichelle C. Whitlock, Shana Y. Trostel +6 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

medRxiv(2022)10.1101/2022.06.04.22276001
N/A
0DataRank · unranked
1 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more